227 related articles for article (PubMed ID: 10226552)
21. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
Selcer KW; Hegde PV; Li PK
Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
[TBL] [Abstract][Full Text] [Related]
22. Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).
Nguyen BL; Chetrite G; Pasqualini JR
Breast Cancer Res Treat; 1995 May; 34(2):139-46. PubMed ID: 7647331
[TBL] [Abstract][Full Text] [Related]
23. Control of sulfatase and sulfotransferase activities by medrogestone in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines.
Chetrite GS; Ebert C; Wright F; Philippe AC; Pasqualini JR
J Steroid Biochem Mol Biol; 1999; 70(1-3):39-45. PubMed ID: 10529001
[TBL] [Abstract][Full Text] [Related]
24. Estradiol as an anti-aromatase agent in human breast cancer cells.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2006 Jan; 98(1):12-7. PubMed ID: 16413774
[TBL] [Abstract][Full Text] [Related]
25. Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
Stute P; Götte M; Kiesel L
Breast Cancer Res Treat; 2008 Apr; 108(3):363-74. PubMed ID: 17546497
[TBL] [Abstract][Full Text] [Related]
26. Steroid metabolism in breast cancer.
Foster PA
Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
[TBL] [Abstract][Full Text] [Related]
27. Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues.
Chetrite GS; Cortes-Prieto JC; Philippe JC; Pasqualini JR
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):289-92. PubMed ID: 17481887
[TBL] [Abstract][Full Text] [Related]
28. The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.
Pasqualini JR; Chetrite G
Anticancer Res; 2008; 28(4B):2129-33. PubMed ID: 18751385
[TBL] [Abstract][Full Text] [Related]
29. Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
Couture P; Thériault C; Simard J; Labrie F
Endocrinology; 1993 Jan; 132(1):179-85. PubMed ID: 8380373
[TBL] [Abstract][Full Text] [Related]
30. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
[TBL] [Abstract][Full Text] [Related]
31. Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells.
Mutoh K; Tsukahara S; Mitsuhashi J; Katayama K; Sugimoto Y
Cancer Sci; 2006 Nov; 97(11):1198-204. PubMed ID: 16925584
[TBL] [Abstract][Full Text] [Related]
32. Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cells.
Nozawa T; Suzuki M; Takahashi K; Yabuuchi H; Maeda T; Tsuji A; Tamai I
J Pharmacol Exp Ther; 2004 Dec; 311(3):1032-7. PubMed ID: 15328376
[TBL] [Abstract][Full Text] [Related]
33. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
[TBL] [Abstract][Full Text] [Related]
34. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
35. [New method for the determination of estrogen and progesterone receptors in human breast cell lines].
Olea N; Devleeschower N; Leclercq G
Rev Esp Fisiol; 1985 Dec; 41(4):373-80. PubMed ID: 4095360
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
[TBL] [Abstract][Full Text] [Related]
37. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
38. 17 beta-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin.
Poutanen M; Moncharmont B; Vihko R
Cancer Res; 1992 Jan; 52(2):290-4. PubMed ID: 1728403
[TBL] [Abstract][Full Text] [Related]
39. Possible function of 17 beta-hydroxysteroid dehydrogenase in preimplantation hamster embryos.
Wu JT; Matsumoto PS
J Exp Zool; 1985 Feb; 233(2):243-6. PubMed ID: 2982996
[TBL] [Abstract][Full Text] [Related]
40. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
